APLT / Applied Therapeutics, Inc. (NasdaqGM) - Forecast, Price Target, Estimates, Predictions. Applied Therapeutics Inc (APLT) has a Smart Score of 5 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. The latest Applied Therapeutics stock prices, stock quotes, news, and APLT history to help you invest and trade smarter. Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products.
Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Find the latest analyst research, reports, and ratings for Applied Therapeutics, Inc. Common Stock (APLT) at blue-host.ru Applied Therapeutics' stock is up on mid-stage results for metabolic drug. Shares of Applied Therapeutics Inc. jumped 27% in premarket trading on Wednesday. Key statistics. On Friday, Applied Therapeutics Inc (APLT:NMQ) closed at , % below its week high of , set on Feb 28, Data delayed at. Track Applied Therapeutics Inc (APLT) Stock Price, Quote, latest community messages, chart, news and other stock related information. NEW YORK, March 28, (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of. Applied Therapeutics Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range - 52 Wk Range - Stock analysis for Applied Therapeutics Inc (APLT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company. View the APLT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Applied Therapeutics. The Investor Relations website contains information about Applied Therapeutics's business for stockholders, potential investors, and financial analysts. According to 5 analysts, the average rating for APLT stock is "Strong Buy." The month stock price forecast is $, which is an increase of % from the.
Applied Therapeutics Stock (NASDAQ: APLT) stock price, news, charts, stock research, profile. Open, $ Close, -. Volume / Avg. K / M. Applied Therapeutics targets molecules and pathways in diseases, like Galactosemia and Diabetic Cardiomyopathy, to create transformative treatments. Discover real-time Applied Therapeutics, Inc. Common Stock (APLT) stock prices, quotes, historical data, news, and Insights for informed trading and. Applied Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. APLT updated stock price target summary. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Find the latest Applied Therapeutics Inc (APLT) stock forecast, month price target, predictions and analyst recommendations. The average price target for Applied Therapeutics Inc is $ This is based on 5 Wall Streets Analysts month price targets, issued in the past 3 months. The current price of APLT is USD — it has decreased by −% in the past 24 hours. Watch Applied Therapeutics, Inc. stock price performance more closely. Applied Therapeutics (APLT) Surges % in a Month: Here's Why. Applied Therapeutics (APLT) surges % in a month due to encouraging updates from two separate.
Is Applied Therapeutics, Inc. (APLT) a buy, sell, or hold? 6 analysts have issued ratings. Wall Street analysts rate APLT as Very Bullish on average, for a Wall. Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Applied Therapeutics, Inc. Announces Upsizing and Pricing of Public Offering of 2,, Shares of Common Stock · $ per share, at a price to the public. Stock Price Forecast. The 4 analysts with month price forecasts for APLT stock have an average target of , with a low estimate of and a high. On average, Wall Street analysts predict that Applied Therapeutics's share price could reach $ by Jul 17, The average Applied Therapeutics stock.
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated. Applied Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APLT. The last closing price for Applied Therapeutics was. Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $ · Market Cap. $ M · Shares Outstanding. M · Public Float. M · Yield. APLT is not. Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting. Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular. APLT - Applied Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGM).